Recursion OS
Approach
Approach
Science
Company Materials
Impact
Industry
ESG
Pipeline
Partners
Investors
About
Team
Story
Values
News
Press
Blogs
Careers
Open Positions
About SLC
COVID-19 Response
Recursion OS
Approach
Approach
Science
Company Materials
Impact
Industry
ESG
Pipeline
Partners
Investors
About
Team
Story
Values
News
Press
Blogs
Careers
Open Positions
About SLC
COVID-19 Response
News & Views.
Recursion Provides Business Updates and Reports Second Quarter 2022 Financial Results
August 9, 2022
Recursion to Participate in Upcoming Investor Conference
August 2, 2022
Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
July 21, 2022
View All Articles
